Campral and Restlessness aggravated - a phase IV clinical study of FDA data

Summary:

Restlessness aggravated is reported as a side effect among people who take Campral (acamprosate calcium), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Effexor Xr, and have Depression.

The phase IV clinical study analyzes which people have Restlessness aggravated when taking Campral. It is created by eHealthMe based on reports of 820 people who have side effects when taking Campral from the FDA, and is updated regularly.

What is Campral?

Campral has active ingredients of acamprosate calcium. It is often used in alcoholism. eHealthMe is studying from 1,007 Campral users. Check the latest studies of Campral.

What is Restlessness aggravated?

Restlessness aggravated (not able to rest) is found to be associated with 1,520 drugs and 563 conditions by eHealthMe. Check the latest studies of Restlessness aggravated.

On Jul, 16, 2026

820 people reported to have side effects when taking Campral.
Among them, 14 people (1.71%) have Restlessness aggravated.

Could Campral cause Restlessness aggravated?

Among these 14 people:

How long have people been on Campral when they have Restlessness aggravated? *

What is the gender of people who have Restlessness aggravated when taking Campral? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Restlessness aggravated when taking Campral? *

What are other drugs people take besides Campral? *

What are other side effects people have besides Restlessness aggravated? *

Aggression: 4 people, 28.57%
Drowsiness: 3 people, 21.43%
Sleep Disorder: 3 people, 21.43%
Mania (a state of abnormally elevated or irritable mood): 3 people, 21.43%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 21.43%
Depression: 3 people, 21.43%
Mood Swings (an extreme or rapid change in mood): 3 people, 21.43%
Weight Decreased: 2 people, 14.29%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 14.29%
Erection Problems: 2 people, 14.29%

What are the existing conditions these people have? *

Pain: 3 people, 21.43%
Depression: 3 people, 21.43%
Stress And Anxiety: 2 people, 14.29%
Quit Smoking: 2 people, 14.29%
Hypersensitivity: 2 people, 14.29%
Drowsiness: 2 people, 14.29%
Alcohol Withdrawal Syndrome: 2 people, 14.29%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 7.14%
Insomnia (sleeplessness): 1 person, 7.14%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Campral and have Restlessness aggravated?

- Check whether Restlessness aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Campral:

Campral (1,007 reports)

Browse all side effects of Campral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Restlessness aggravated:

Restlessness aggravated (1,520 drugs)

Browse all the conditions that are associated with Restlessness aggravated:

Restlessness aggravated (563 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acamprosate calcium (the active ingredients of Campral) and Campral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.